1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Global Migraine Drugs Market 2016-2020

Global Migraine Drugs Market 2016-2020

  • May 2016
  • -
  • Infiniti Research Limited
  • -
  • 63 pages

Summary

Table of Contents

Search Inside

About Migraines

A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men owing to the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs, antisickness medicines, and triptans are used for the treatment of the disease.

Technavio’s analysts forecast the global migraine drugs market to grow at a CAGR of 4.56% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global migraine drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that will be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Migraine Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Allergan
- Endo International
- GlaxoSmithKline
- Impax
- Pfizer


Other prominent vendors
- Abbott
- Aegis Therapeutics
- Aeriel BioPharma
- Alder Biopharmaceuticals
- Amgen
- Astellas
- AstraZeneca
- Bayer
- CoLucid
- Dr. Reddy’s Laboratories
- Eisai
- Eli Lilly
- Ethypharm
- IntelGenx
- Johnson & Johnson
- Klaria
- Kowa Pharmaceuticals America
- Luitpold Pharmaceuticals
- Meda
- Merck
- OptiNose
- Pfizer
- Pozen
- Raptor
- RedHill
- SUDA
- Teva
- TG Therapeutics
- NValeant
- Winston Pharmaceuticals
- Zogenix

Market driver
- Growing awareness about migraine and its treatment options
- For a full, detailed list, view our report

Market challenge
- Lack of proper diagnosis
- For a full, detailed list, view our report

Market trend
- Antimigraine devices and headbands
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Migraine  - Market Insights, Epidemiology and Market Forecast-2023

Migraine  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Migraine - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Dysmenorrhea  - Market Insights, Epidemiology and Market Forecast-2023

Dysmenorrhea  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dysmenorrhea - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.